Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

Abstract

An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofı́a Rodrı́guez-Reyna. In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiologı́a y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.